Inhalation of nebulized nitroglycerin, a nitric oxide donor, for the treatment of pulmonary hypertension induced by high pulmonary blood flow

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Heart and Vessels

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00380-005-0876-yPMID 16715192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protection from the Dark Side of NO: Signaling and Cellular Defenses Against Nitric Oxide Toxicity

  2004cited by this paper
• The modulating effect of L-arginine on collagen metabolism of pulmonary artery in pulmonary hypertension induced by a left-to-right shunt.

  2002cited by this paper
• Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53

  2002cited by this paper
• L-arginine impacts pulmonary vascular structure in rats with an aortocaval shunt.

  2002cited by this paper
• Nitric oxide synthase expression in lungs of pulmonary hypertensive patients with heart disease.

  2001cited by this paper
• Nebulized nitroglycerin in children with pulmonary hypertension secondary to congenital heart disease.

  1999cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord (neuropeptidesyamphibiansyevolution)

  1998cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension.

  1998cited by this paper
• Effects of Inhalation of Nitroglycerin on Hypoxic Pulmonary Vasoconstriction

  1998cited by this paper
• Cell cycle effects of nitric oxide on vascular smooth muscle cells.

  1997cited by this paper
• Heterologous desensitization of smooth muscle to K+ depolarization: retarded stimulus-[Ca2+]i coupling.

  1997cited by this paper
• DNA damage by nitric oxide.

  1996cited by this paper
• Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow.

  1996cited by this paper
• Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

  1995cited by this paper
• Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

  1995cited by this paper
• An improved mathematical approach for the assessment of the medial thickness of pulmonary arteries.

  1993cited by this paper
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

  1989cited by this paper

• Gas-based therapeutics and delivery platforms in cancer immunotherapy.

  2025cites this paper
• Nebulized nitroglycerin as an adjuvant drug in management of persistent pulmonary hypertension of newborns: a randomized controlled trial

  2025cites this paper
• Multifaceted role of nitric oxide in vascular dementia

  2025cites this paper
• Intravenous anesthesia with nitroglycerin inhalation for surgical abortion in a patient with severe congenital heart disease and low oxygen saturation

  2018cites this paper
• Identification of a Novel Hybridization from Isosorbide 5-Mononitrate and Bardoxolone Methyl with Dual Activities of Pulmonary Vasodilation and Vascular Remodeling Inhibition on Pulmonary Arterial Hypertension Rats.

  2018cites this paper
• Intratracheal administration of isosorbide dinitrate improves pulmonary artery pressure and ventricular remodeling in a rat model of heart failure following myocardial infarction

  2017cites this paper
• A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.

  2016cites this paper
• Sulfur Dioxide Protects Against Collagen Accumulation in Pulmonary Artery in Association With Downregulation of the Transforming Growth Factor β1/Smad Pathway in Pulmonary Hypertensive Rats

  2016cites this paper
• Inhibition of survivin promotes pulmonary arterial smooth muscle cell apoptosis in high blood flow-induced pulmonary arterial hypertension in rats

  2016cites this paper
• Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.

  2011cites this paper
• Role of Endothelium in the Development of Pulmonary Hypertension

  2011influential citation
• Is nitroglycerin effective in treatment of haemoptysis?

  2010cites this paper
• Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat

  2008cites this paper
• Electron paramagnetic resonance investigation on modulatory effect of benidipine on membrane fluidity of erythrocytes in essential hypertension

  2008cites this paper
• Sodium hydrosulfide alleviates pulmonary artery collagen remodeling in rats with high pulmonary blood flow

  2008cites this paper
• Urotensin-II in the lung: A matter for vascular remodelling and pulmonary hypertension?

  2007cites this paper
• In vivo animal models for drug delivery across the lung mucosal barrier.

  2007cites this paper
• The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin

  2006cites this paper